United Kingdom - Hope of fast prostate cancer testClinical disease managementDiagnostic screeningIll health preventionEmerald Group Publishing LimitedInternational Journal of Health Care Quality Assurance
For common signs and symptoms of prostate cancer, please visit the Check4Cancer ‘Advice and Awareness’ page at this link. Why should I have a PSACheck? Prostate cancer is the most common cancer in men across the UK with more than 47,700 men diagnosed with prostate cancer every year....
Dr. Schwen on focal therapies for prostate cancer Speaking of Urology: Liquid biopsy in prostate cancer Dr. Kishan highlights findings from the MIRAGE trial in prostate cancer Dr. Laviana on decisional regret after prostate cancer treatment Study finds lack of Black and Latinx representation in on...
The current approach to prostate cancer diagnosis in the UK and many other HICs relies on "informed choice" PSA testing, meaning men aged 50 or over with no symptoms can request the test from their doctor after a discussion of the risks and benefits. Accordi...
The prostate cancer condition center is a comprehensive resource for clinical news and expert insights on prostate cancer. Read more at OncLive.
In the ERSPC trial, the prostate cancer mortality rate ratio in the screening vs control group among men 70 years and older at randomization was 1.17 (95% CI, 0.82-1.66); however, a statistical test found no significant heterogeneity across age groups. In the PLCO trial, the analogous rate...
The 4Kscore® Test is a non-invasive blood test that assesses a patient’s probability for aggressive prostate cancer after an abnormal PSA or DRE result.
Prostate cancer (PC) is one of the most common cancers in males and the fifth leading reason of death. Age, ethnicity, family history, and genetic defects are major factors that determine the aggressiveness and lethality of PC. The African population is
When testing for prostate cancer, as many as 75% of men with a raised prostate-specific antigen (PSA) have a benign biopsy result. Little is known about the psychological effect of this result for these men. In all, 330 men participating in the prostate
The gleason scale is an important diagnostic tool to assess the progression of prostate cancer. If yourPSA test resultsand/or DRE (digital rectal exam) come up positive, the next course of action is usually a prostate biopsy (surgical removal of a small section of prostate cells). ...